MED vs PATH
MEDIFAST INC (MED) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
MEDIFAST INC (MED) is a personal services company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported MED revenue for 2024-12-31 was $602.5M. Net income was $2.1M. Revenue was down 43.8% from 2023-12-31 to 2024-12-31. MED currently screens at market cap $125.3M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
MED currently screens at market cap $125.3M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the MED and PATH stock pages for the full models.
Not investment advice.